Trial intelligence / Profile preview

Pregabalin SR vs IR in Diabetic Peripheral Neuropathic Pain

NCT05624853Phase 4Completed

Sponsor
Yuhan
Start
May 2020
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Yuhan. Started May 2020; status: completed.

02

Drugs

pregabalin
03

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT05624853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05624853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call